Skip to main content
Premium Trial:

Request an Annual Quote

Agilent to Launch CGH Microarray Product at LabAutomation Conference

NEW YORK, Jan. 20 (GenomeWeb News) - Agilent will launch its Comparative Genomic Hybridization microarray product on Jan. 31, according to an e-mail sent by the company to publicize a related press briefing.


The product, which examines chromosomal changes related to cancer, will be introduced in conjunction with the LabAutomation conference in San Jose, Calif.Further product details were not available.


Chris van Ingen, head of Agilent's Life Sciences and Chemical Analysis business unit, said at the company's annual analyst meeting in New York in December that the application of microarray-based CGH and location analysis will drive short-term growth for the life science segment of the LSCA unit. This group sells genomics and proteomics tools, including CGH- and location-analysis microarray products, as well as pharmaceutical analysis tools. Van Ingen's comments were reported in the Dec. 16 issue of GenomeWeb News' sister publication, BioCommerce Week.


"The microarray market for gene-expression profiling and genotyping is still fluctuating in growth but the new applications will fuel growth in gene expression higher than 8 to 12 percent," said van Ingen. "It's still a small portion of our business."


The company also plans to introduce a microarray wash station in "early summer," according to the e-mail.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.